Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
0.00
↓ 100% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineCompressed
Average
27.95
Historical baseline
PeriodValueYoY Change
20250.00-100.0%
20243.02-97.9%
2023142.28+195.0%
202248.23+56.6%
202130.79+13.3%
202027.19-
20190.00-
20180.00-
20170.00-